Form 4: Semler Scientific Director Eric Semler Acquires 27,000 Stock Options

Director Eric Semler acquired 27,000 stock options in Semler Scientific, Inc. as part of non-employee director compensation.

Summary

• On May 24, 2024, Eric Semler, a director of Semler Scientific, Inc., acquired 27,000 stock options.
• The options were granted as non-employee director compensation for his appointment to a newly formed committee of the board.
• The exercise price of the options is $23.32.
• 1/24th of the underlying shares vested immediately on the grant date, with the remainder vesting monthly until April 24, 2026.
• The options expire on May 24, 2026.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options is a standard practice and suggests confidence in the company's future performance. The vesting schedule promotes long-term alignment.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes long-term commitment and performance.

Industry Context

Stock option grants to directors are a common practice in the industry to align their interests with the company's long-term performance.

Comparison to Industry Standards

• Stock option grants are a typical component of director compensation packages in the tech and healthcare industries, often used to incentivize performance and align interests with shareholders.
• The vesting schedule of these options, with monthly vesting until April 2026, is fairly standard, encouraging long-term commitment from the director.
• Comparable companies in the medical device or diagnostics sector often use similar equity-based compensation strategies to attract and retain board members.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the director's interests with the company's success.
• The director is incentivized to contribute to the company's growth and profitability.

Key Dates